Your doctor or pharmacist may already be aware of any possible drug interactions and may be monitoring you for them. Do not start, stop, or change the dosage of any medicine before checking with your doctor or pharmacist first.
Avoid taking MAO inhibitors (e.g., furazolidone, isocarboxazid, linezolid, moclobemide, phenelzine, procarbazine, rasagiline, selegiline, tranylcypromine) within 2 weeks before,...
Read moreBrand Name: Vyvanse Generic Name: lisdexamfetamine dimesylate Usage: Vyvanse has been approved by the Food and Drug Administration to treat... Read more »
The U.S. Food and Drug Administration has approved Vyvanse for the treatment of attention-deficit/hyperactivity disorder in adults. Vyvanse is a new... Read more »
According to the drug manufacturer Shire, the Food and Drug Administration has approved Vyvanse for the treatment of attention-deficit/hyperactivity... Read more »
A new study by the maker of Vyvanse found that the medication controlled attention- deficit/hyperactivity disorder symptoms in children 6 to 12 years... Read more »
Vyvanse is effective in treating adults with attention-deficit/hyperactivity disorder, according to new clinical trial results. In the study, 414... Read more »